Intrinsic4D Extends Convertible Debenture Financing

TORONTO, ONTARIO--(Marketwired - May 4, 2016) -

NOT FOR DISSEMINATION IN THE U.S. OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES

Intrinsic4D Inc. ("Intrinsic4D") (TSX VENTURE:IFD) announces that it has extended its brokered private placement (the "Offering") of secured convertible debentures (the "Debentures"), previously announced on March 18, 2016, through Gravitas Securities, Inc. (formerly Portfolio Strategies Securities Inc.), P.S. Securities (USA) Inc. and Euro Pacific Canada Inc. for up to a maximum of CAD$5 million. A second and final tranche is scheduled to close on or before May 17, 2016.

About Intrinsic4D Inc.

Intrinsic4D, through its Authentic brand, is the developer of the patented and FDA-cleared transformative software-as-a-service medical platform servicing the medical-legal industry. Through its patented and disruptive Stenosis Severity Mapping (SSM) Cardio solution, it aims to reduce the $13 billion of unnecessary cardiac catheterizations performed annually, which are attributed to false positive reads of diagnostic tests for evaluating coronary artery disease.

Disclaimer for Forward-Looking Information

Certain statements contained in this press release constitute forward-looking information within the meaning of applicable securities laws. Forward-looking information may relate to the Corporation's future outlook and anticipated events or results.. Particularly, statements regarding future results, performance, achievements and prospects or opportunities for the Corporation are forward looking statements. Some of the specific forward looking statements in this press release include, but are not limited to, the final approval of the Offering by the TSXV and the completion of the second tranche of the Offering. Although the forward- looking statements contained in this press release are based upon assumptions that management of the Corporation believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, including the receipt of executed subaciton agreements and funds by subscribers for Debentures, many of which are beyond the Corporation's control, which may cause actual results to differ materially from those expressed or implied by such forward- looking statements. The forward-looking statements made in this press release relate only to events or information as of the date hereof. Except as required by applicable law, the Corporation undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.

Neither TSX nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

The securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "1933 Act"), or under any state securities laws, and may not be offered or sold, directly or indirectly, or delivered within the United States or to, or for the account or benefit of, U.S. persons (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. This news release does not constitute an offer to sell or a solicitation to buy such securities in the United States.